|
1
|
Sexual transmission of hepatitis C virus among monogamous heterosexual couples: the HCV partners study.
|
Hepatology
|
2013
|
3.35
|
|
2
|
Changes in gene expression during pegylated interferon and ribavirin therapy of chronic hepatitis C virus distinguish responders from nonresponders to antiviral therapy.
|
J Virol
|
2007
|
2.45
|
|
3
|
Genome-wide hepatitis C virus amino acid covariance networks can predict response to antiviral therapy in humans.
|
J Clin Invest
|
2008
|
2.08
|
|
4
|
Immune evasion versus recovery after acute hepatitis C virus infection from a shared source.
|
J Exp Med
|
2005
|
1.93
|
|
5
|
Multiple effects of silymarin on the hepatitis C virus lifecycle.
|
Hepatology
|
2010
|
1.92
|
|
6
|
Loss of viral fitness and cross-recognition by CD8+ T cells limit HCV escape from a protective HLA-B27-restricted human immune response.
|
J Clin Invest
|
2009
|
1.46
|
|
7
|
A novel unsupervised method to identify genes important in the anti-viral response: application to interferon/ribavirin in hepatitis C patients.
|
PLoS One
|
2007
|
1.39
|
|
8
|
Pretreatment sequence diversity differences in the full-length hepatitis C virus open reading frame correlate with early response to therapy.
|
J Virol
|
2007
|
1.38
|
|
9
|
Differential in vitro effects of intravenous versus oral formulations of silibinin on the HCV life cycle and inflammation.
|
PLoS One
|
2011
|
1.27
|
|
10
|
β-Thujaplicinol inhibits hepatitis B virus replication by blocking the viral ribonuclease H activity.
|
Antiviral Res
|
2013
|
1.07
|
|
11
|
A general method for nested RT-PCR amplification and sequencing the complete HCV genotype 1 open reading frame.
|
Virol J
|
2005
|
1.06
|
|
12
|
Hepatitis C virus diversity and evolution in the full open-reading frame during antiviral therapy.
|
PLoS One
|
2008
|
1.02
|
|
13
|
Translation of duck hepatitis B virus reverse transcriptase by ribosomal shunting.
|
J Virol
|
2004
|
0.99
|
|
14
|
Identification of an essential molecular contact point on the duck hepatitis B virus reverse transcriptase.
|
J Virol
|
2005
|
0.97
|
|
15
|
Contribution of genome-wide HCV genetic differences to outcome of interferon-based therapy in Caucasian American and African American patients.
|
PLoS One
|
2010
|
0.95
|
|
16
|
Detection and characterization of cytoplasmic hepatitis B virus reverse transcriptase.
|
J Gen Virol
|
2004
|
0.94
|
|
17
|
Separation of near full-length hepatitis C virus quasispecies variants from a complex population.
|
J Virol Methods
|
2007
|
0.93
|
|
18
|
Herpes simplex virus 2 UL13 protein kinase disrupts nuclear lamins.
|
Virology
|
2009
|
0.93
|
|
19
|
Kinetics of synthesis and turnover of the duck hepatitis B virus reverse transcriptase.
|
J Biol Chem
|
2002
|
0.91
|
|
20
|
Herpes simplex virus 2 VP22 phosphorylation induced by cellular and viral kinases does not influence intracellular localization.
|
Virology
|
2004
|
0.88
|
|
21
|
The duck hepatitis B virus reverse transcriptase functions as a full-length monomer.
|
J Biol Chem
|
2006
|
0.88
|
|
22
|
An interdomain RNA binding site on the hepadnaviral polymerase that is essential for reverse transcription.
|
Virology
|
2009
|
0.86
|
|
23
|
How further suppression of virus replication could improve current HBV treatment.
|
Expert Rev Anti Infect Ther
|
2013
|
0.85
|
|
24
|
Suppression of mRNA accumulation by the duck hepatitis B virus reverse transcriptase.
|
Virology
|
2006
|
0.85
|
|
25
|
Hepatitis C virus envelope glycoprotein signatures are associated with treatment failure and modulation of viral entry and neutralization.
|
J Infect Dis
|
2013
|
0.85
|
|
26
|
RNA elements directing translation of the duck hepatitis B Virus polymerase via ribosomal shunting.
|
J Virol
|
2011
|
0.83
|
|
27
|
Substrate specificity of the herpes simplex virus type 2 UL13 protein kinase.
|
Virology
|
2008
|
0.83
|
|
28
|
Combining genetic and biochemical approaches to identify functional molecular contact points.
|
Biol Proced Online
|
2006
|
0.81
|
|
29
|
The GB virus C (GBV-C) NS3 serine protease inhibits HIV-1 replication in a CD4+ T lymphocyte cell line without decreasing HIV receptor expression.
|
PLoS One
|
2012
|
0.81
|
|
30
|
Coordinated evolution among hepatitis C virus genomic sites is coupled to host factors and resistance to interferon.
|
In Silico Biol
|
2012
|
0.80
|
|
31
|
The duck hepatitis B virus polymerase and core proteins accumulate in different patterns from their common mRNA.
|
Virology
|
2003
|
0.79
|
|
32
|
Comparative analysis of hepatitis B virus polymerase sequences required for viral RNA binding, RNA packaging, and protein priming.
|
J Virol
|
2013
|
0.78
|
|
33
|
Genome-wide networks of amino acid covariances are common among viruses.
|
J Virol
|
2012
|
0.78
|
|
34
|
Host factor-targeted hepatitis B virus therapies.
|
Intervirology
|
2014
|
0.77
|
|
35
|
Pre-P is a secreted glycoprotein encoded as an N-terminal extension of the duck hepatitis B virus polymerase gene.
|
J Virol
|
2008
|
0.76
|
|
36
|
Localization of duck hepatitis B virus polymerase within cells.
|
Methods Mol Med
|
2004
|
0.76
|